Klaus Schiene

This inventor holds 56 USPTO granted patents and 48 published patent applications, plus 7 CIPO patents and 37 EPO patents, primarily in Pharmaceutical Compositions (CPC class A61K). Top assignees: Gruenenthal Gmbh, Grunenthal Gmbh, Medifron Dbt Inc.. Active years: 2006-2022.

USPTO Granted Patents = 56 (Patent Applications = 48)

% Patents Active = 32.1

CIPO Patents = 7 (Patent Applications = 7)

EPO Patents = 37 (Patent Applications = 41)

Average Co-Inventor Count = 5.5

ph-index = 8

Forward Citations = 147(Granted Patents)

Forward Citations (Not Self Cited) = 130(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Juchen, DE (2011 - 2012)
Düsseldorf, DE (2006 - 2014)
Jüchen, DE (2011 - 2017)
Duesseldorf, DE (2007 - 2019)
Juechen, DE (2011 - 2022)

Company Filing History:

Park Therapeutics, Inc.

patents

Years Active: 2006-2022

Loading Chart...

Areas of Expertise:

Vanilloid Receptor Ligands

Pharmaceutical Compositions

Pain Inhibition

Analgesic Combinations

COX-II Inhibitors

Carboxamide Derivatives

Oxazole Compounds

Phenylureas

Sulfonamide Compounds

Amino Derivatives

KCNQ2/3 Modulators

mGluR5 Regulation

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11311504 - Pharmaceutical composition comprising (1R,4R)-6'- fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro [cyclohexane-1,1′-pyrano- [3,4,b ]indol] -4-amine and paracetamol or propacetamol (2022-04-26),

2. 10829480 - 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-l,3-diaza-spiro-[4.5]-decane derivatives (2020-11-10),

3. 10813891 - Method of inhibiting chronification of pain (2020-10-27),

4. 10813890 - Pharmaceutical combination (2020-10-27),

5. 10807989 - 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives (2020-10-20),

6. 10471079 - Combination of selected analgesics and COX-II inhibitors (2019-11-12),

7. 10398657 - Method of inhibiting chronification of pain (2019-09-03),

8. 10206890 - Pharmaceutical combination (2019-02-19),

9. 10076510 - Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative (2018-09-18),

10. 9855286 - Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component (2018-01-02),

11. 9771359 - Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II (2017-09-26),

12. 9624209 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2017-04-18),

13. 9320729 - Pharmaceutical composition comprising (1r,4r)-6'-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative (2016-04-26),

14. 9308196 - Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam (2016-04-12),

15. 9120756 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2015-09-01),

Title: Inventor Klaus Schiene: Revolutionizing Technology in Juechen, DE

Introduction: Klaus Schiene is a visionary inventor based in Juechen, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Klaus Schiene holds several patents in various technological domains, including advancements in renewable energy systems, smart home automation, and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Klaus Schiene has established himself as a leading figure in the tech industry, with a strong focus on creating solutions that are both innovative and environmentally friendly.

Collaborations: Throughout his career, Klaus Schiene has collaborated with top research institutions, universities, and leading tech companies to bring his inventions to life. His collaborative efforts have resulted in cutting-edge products that have had a significant impact on the industry.

Conclusion: Klaus Schiene's passion for innovation and his dedication to creating a more sustainable future through technology make him a true pioneer in the field of invention. His work continues to inspire and shape the technological landscape for years to come.